FIELD: biotechnology.
SUBSTANCE: invention relates to the field of biotechnology and medicine. A method is proposed for predicting the degree of risk of developing extrapyramidal side effects during haloperidol therapy in patients with schizophrenia spectrum disorders.
EFFECT: predicted for a particular patient risk of developing extrapyramidal side effects of haloperidol therapy.
1 cl, 2 ex
| Title | Year | Author | Number |
|---|---|---|---|
| METHOD OF SELECTING TREATMENT TACTICS FOR PATIENTS WITH ANTIPSYCHOTIC-INDUCED EXTRAPYRAMIDAL DISORDERS | 2022 |
|
RU2810798C1 |
| METHOD FOR ESTABLISHING A PREDISPOSITION IN THE FORMATION OF POLAR STRESS SYNDROME IN STUDENTS AGED 7-13 YEARS LIVING IN THE POLAR REGIONS | 2022 |
|
RU2793062C1 |
| METHOD FOR SELECTING THERAPEUTIC APPROACH IN PATIENTS WITH SCHIZOPHRENIA | 2022 |
|
RU2821045C1 |
| METHOD FOR PREDICTING THE EFFICIENCY OF HALOPERIDOL THERAPY FOR THE TREATMENT OF DISORDERS ACCOMPANIED BY THE DEVELOPMENT OF PSYCHOTIC SYMPTOMS | 2017 |
|
RU2643944C1 |
| METHOD OF DETERMINING EARLY MANIFESTATIONS OF DORSALGIA IN CHILDREN OF SECONDARY SCHOOL AGE 11-15 YEARS OLD, ASSOCIATED WITH LEAD CONTAMINATION OF BIOLOGICAL MEDIA | 2023 |
|
RU2807895C1 |
| METHOD FOR EARLY DIAGNOSIS OF FUNCTIONAL DYSPEPSIA IN CHILDREN OF 4-6 YEARS OLD, ASSOCIATED WITH EXCESSIVE CONTAMINATION OF BIOMEDIA WITH LEAD | 2024 |
|
RU2836997C1 |
| METHOD FOR DETERMINING THE GENETIC PREDISPOSITION TO THE DEVELOPMENT OF MULTIDRUG-RESISTANT TUBERCULOSIS MYCOBACTERIUM TUBERCULOSIS IN HIV INFECTION | 2020 |
|
RU2750715C1 |
| METHOD FOR SELECTION OF PERINDOPRIL DOSAGE FORPATIENTS WITH ISCHEMIC HEART DISEASE ON BACKGROUND OF ARTERIAL HYPERTENSION | 2016 |
|
RU2642284C1 |
| METHOD FOR IMPROVING DRUG USE SAFETY IN TREATING PATIENTS WITH ALCOHOL WITHDRAWAL SYNDROME | 2018 |
|
RU2690522C1 |
| METHOD FOR DETECTING THE PREDISPOSITION TO ADDICTIVE DISORDERS IN THE FORM OF ALCOHOLIC ADDICTION AND/OR CO-ADDICTION | 2006 |
|
RU2296994C1 |
